Blood sample study for sickle cell trait and controls
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study collects blood samples to learn more about sickle cell-related genetics and biology. You might benefit indirectly by helping researchers understand the condition, even though this is laboratory research rather than a medication trial.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have sickle cell trait, or a known sickle-hemoglobin genetic condition involving one or two genes
- Or be a healthy volunteer for comparison/control testing
- Be able to understand that this study is laboratory research
- Have already been screened for HIV, hepatitis B, and hepatitis C through a separate NIH protocol (those conditions must be negative)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood and urine samples from adults to help researchers understand diseases affecting blood vessels. Your donation helps scientists develop better treatments.
This study looks at whether certain genes make people with sickle cell disease more likely to develop an immune reaction to blood transfusions. It aims to help doctors predict transfusion risks and improve care.
This study collects common body samples to learn how different globin gene variants work and how they relate to health. Your samples may also be used later for new research, including genetic testing.
This study asks adults with sickle cell disease about what they eat and their eating routines. The goal is to understand diet patterns in sickle cell and how they may relate to health, which could help future care and guidance.
This study is for adults who have or might have sickle cell trait (carrying the sickle cell gene but not the disease). It aims to understand the health effects of sickle cell trait over time by following participants and collecting health information.
This trial tests a “biochip” device using samples from people with sickle cell disease. If it works, it may help doctors study sickle cell biology more accurately using patient samples.
Hear when a new Sickle Cell Trait trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.